Your browser doesn't support javascript.
loading
Role of IL-17A receptor blocking in melanocyte survival: A strategic intervention against vitiligo.
Bhardwaj, Supriya; Bhatia, Alka; Kumaran, Muthu Sendhil; Parsad, Davinder.
Afiliação
  • Bhardwaj S; Departmet of Dermatology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.
  • Bhatia A; Department of Experimental Medicine & Biotechnology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.
  • Kumaran MS; Departmet of Dermatology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.
  • Parsad D; Departmet of Dermatology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.
Exp Dermatol ; 28(6): 682-689, 2019 06.
Article em En | MEDLINE | ID: mdl-30120811
ABSTRACT
Cytokines regulate immune response and inflammation and play an important role in depigmentation process of an autoimmune disease, vitiligo. We sought to determine how inflammatory cytokines influence the progression of vitiligo, and based on that, we develop a logical therapeutic intervention using primary melanocyte culture. Melanocytes were cultured and exposed to IL-17A, IL-1ß, IFN-γ and TGF-ß for 4 days. Melanocytes proliferation, tyrosinase assay and melanin content were measured. Real-Time PCR was used to analyse mRNA expression of genes specific for melanocytes growth and pigmentation. Anti-IL-17A receptor antibody was used to block IL-17A receptors expressed on melanocytes. Protein expression of MITF and TYR was assessed by immunofluorescence and Western blotting. A gradual decline in the melanocyte population, melanin content and tyrosinase activity was observed after different cytokine treatment. The expression of MITF and its downstream genes after blocking with anti-IL-17RA, an increased melanin content, increased expression of TYR, MITF along with its downstream genes, and cell proliferation was observed.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vitiligo / Receptores de Interleucina-17 / Melanócitos / Anticorpos Monoclonais Limite: Humans Idioma: En Revista: Exp Dermatol Assunto da revista: DERMATOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Índia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vitiligo / Receptores de Interleucina-17 / Melanócitos / Anticorpos Monoclonais Limite: Humans Idioma: En Revista: Exp Dermatol Assunto da revista: DERMATOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Índia